FDA Investigator Randall N Johnson

Randall N Johnson has conducted inspections on 86 sites in 1 countries as of 05 Jun 2006. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
86
Last Inspection Date:
05 Jun 2006
Investigator Role:
FDA Investigator
Redica ID:
100001803
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Randall N Johnson:
Andrea J Schmidt, Armando Chavez, MS, Barbara J Rincon, Bichsa T Tran, Brian J Ryan, Carla J Lundi, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cecilia H Kieu, Charles L Larson, Cheryl D Mccall, Christina V Santos, Christopher M Jenner, Darren S Brown, David P Vanhouten, Dennis M Farley, Diana L Ayala, Diana M Rand, Diane Cvan Leeuwen, Djamila Harouaka, Dolores Harper, Dorine J Hagstrom, Hung H Do, MS, Jacob W Reynolds, Jeffery A Johnson, Joel D Hustedt, Joey V Quitania, John A Daubenspeck, John A Gonzalez, Jude C Dikes, Kenneth S Boehnen, Kham Phommachanh, Khoa Nathanv Tran, Kimberly M Lichter, Laura A Munsterman, Laurimer Kuilan Torres, Linda Thai, Marcus F Yambot, Mathew T Thomas, MD, Michelle J Hines, Nataniel Phillips Sylvain, PhD, Nicholas L Hunt, Paul R Whitby, Raymond T Oji, Richmond K Yip, Robert D Tollefsen, Roger F Zabinski, Sandra L Shire, DMD, MPA, Sara Jdent Acosta, Sonia R Peterson, Sue Lee Chan, Tammy Battisti, Thomas J Arista, Thomas R Beilke, Timothy T Kapsala, Tonia L Sawyer, Valerie L Whipp, Vanessa R Muller, Virgilio F Pacio, CSO, Walden H Lee, William J Leonard, Zachary A Bogorad

Randall N Johnson's Documents

Publish Date Document Type Title
December, 2000 FDA 483 ALLERMED LABORATORY, INC. - Form 483, 2000-12-15
October, 2002 FDA 483 Abraxis Bioscience LLC - Form 483, 2002-10-24
September, 2001 EIR Island Kinetics, Inc. d.b.a. CoValence Laboratories - EIR, 2001-09-20
January, 2006 FDA 483 Biotech Research Labs, Inc. - Form 483, 2006-01-20
April, 2000 EIR Loffer, Franklin Md - EIR, 2000-04-19
March, 2002 FDA 483 Abraxis Bioscience LLC - Form 483, 2002-03-01
September, 2001 FDA 483 Response Island Kinetics, Inc. d.b.a. CoValence Laboratories - Form 483R, 2002-01-14
August, 2002 EIR Alberts, David Md - EIR, 2002-08-20
May, 2005 FDA 483 Matrixx Initiatives, Inc. - Form 483, 2005-05-27
May, 2002 EIR Dunlap, Frank E Dr - EIR, 2002-05-09
February, 2004 EIR Siegel, Robert M MD - EIR, 2004-02-11
September, 2001 EIR Lincare Inc. - EIR, 2001-09-21
July, 2001 FDA 483 Kletscher, Bruce A., M.D. - Form 483, 2001-07-11
October, 2002 EIR Lincare Inc. - EIR, 2002-10-30
August, 2002 EIR RLC Labs Inc. - EIR, 2002-08-28
November, 2001 EIR Jeanette Wendt MD - EIR, 2001-10-30
October, 2000 FDA 483 Innovative Clinical Solutions, Ltd. - Form 483, 2000-10-11
October, 2000 EIR Louise Taber, MD - EIR, 2000-10-11
March, 2000 EIR Berger Allergy Assoc Wm Md - EIR, 2000-03-29
November, 2001 EIR Jeanette Wendt MD - EIR, 2001-10-31
December, 2002 FDA 483 Konec Inc. - Form 483, 2002-12-13
September, 2001 FDA 483 Island Kinetics, Inc. d.b.a. CoValence Laboratories - Form 483, 2001-09-20
November, 2001 FDA 483 Jeanette Wendt MD - Form 483, 2001-11-09
March, 2000 EIR Berger Allergy Assoc Wm Md - EIR, 2000-03-28
May, 2005 EIR Matrixx Initiatives, Inc. - EIR, 2005-05-27
July, 2001 EIR Kletscher, Bruce A., M.D. - EIR, 2001-07-11
November, 2001 EIR Jeanette Wendt MD - EIR, 2001-11-09
November, 2000 EIR Discovery Alliance, Inc. - EIR, 2000-11-07
October, 2001 EIR Kirby, Louis C., MD - EIR, 2001-10-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more